CD19 and acute lymphoblastic leukemia: In a pilot study at the Children’s Hospital of Philadelphia, Grupp et al.151 treated 53 children with relapsed/refractory ALL with lymphocyte depleting chemotherapy followed by CD19-directed CAR-Ts.